MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, OMDA had -$24,519K decrease in cash & cash equivalents over the period. $9,596K in free cash flow.

Cash Flow Overview

Change in Cash
-$24,519K
Free Cash flow
$9,596K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Accrued expenses and other curre...
    • Share-based compensation
    • Loss on debt extinguishment
    • Others
Negative Cash Flow Breakdown
    • Repayment of debt principal
    • Accounts receivable
    • Net loss
    • Others

Cash Flow
2025-09-30
2025-06-30
Net loss
-3,178 -14,759
Depreciation and amortization
1,359 2,685
Share-based compensation
3,536 5,674
Loss on debt extinguishment
-2,109 -
Loss on disposal of property and equipment
0 -2
Amortization of debt issuance costs
33 252
Non-cash operating lease expense
65 382
Change in fair value of warrants
212 1,256
Provision for credit losses
995 490
Amortization of deferred commissions
906 1,561
Accounts receivable
9,154 10,360
Inventory
-321 173
Prepaid expenses and other current assets
700 870
Deferred commissions
896 1,423
Other non-current assets
-63 -118
Accounts payable
357 1,016
Operating lease liabilities
0 -415
Accrued expenses and other current liabilities
12,562 -4,780
Deferred revenue
1,632 5,995
Other non-current liabilities
-89 89
Net cash used in operating activities
10,133 -13,260
Purchases of property and equipment
537 586
Capitalized internal-use software costs
1,450 1,913
Net cash used in investing activities
-1,987 -2,499
Proceeds from exercise of stock options
2,085 3,908
Payment of deferred offering costs
2,357 1,927
Repayment of debt principal
30,963 -
Payment of debt extinguishment costs
1,430 -
Proceeds from initial public offering, net of underwriting discounts and commissions
0 160,532
Net cash provided by (used in) financing activities
-32,665 162,513
Net increase (decrease) in cash and cash equivalents
-24,519 146,754
Cash and cash equivalents at beginning of period
76,392 -
Cash and cash equivalents at end of period
198,627 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Accrued expenses andother current...$12,562K Share-based compensation$3,536K Loss on debtextinguishment-$2,109K Deferred revenue$1,632K Depreciation andamortization$1,359K Provision for creditlosses$995K Amortization of deferredcommissions$906K Accounts payable$357K Inventory-$321K Change in fair value ofwarrants$212K Non-cash operating leaseexpense$65K Other non-currentassets-$63K Amortization of debt issuancecosts$33K Net cash used inoperating activities$10,133K Canceled cashflow$14,017K Net increase(decrease) in cash and cash...-$24,519K Canceled cashflow$10,133K Proceeds from exercise ofstock options$2,085K Accounts receivable$9,154K Net loss-$3,178K Deferred commissions$896K Prepaid expenses andother current assets$700K Other non-currentliabilities-$89K Net cash provided by(used in) financing...-$32,665K Canceled cashflow$2,085K Net cash used ininvesting activities-$1,987K Repayment of debtprincipal$30,963K Payment of deferredoffering costs$2,357K Payment of debtextinguishment costs$1,430K Capitalized internal-usesoftware costs$1,450K Purchases of property andequipment$537K

Omada Health, Inc. (OMDA)

Omada Health, Inc. (OMDA)